Aclaris Therapeutics (ACRS) EPS (Basic) (2014 - 2026)
Aclaris Therapeutics' (ACRS) quarterly EPS (Basic) came in at -$0.29 in Q1 2026, down 92.51% year-on-year from -$3.89 in Q1 2025, and down 13.82% quarter-over-quarter from -$0.26 in Q4 2025.
Aclaris Therapeutics (ACRS) EPS (Basic) (2014 - 2026) Analysis & Trends
Aclaris Therapeutics' EPS (Basic) history runs 13 years deep, the most recent figure standing at -$0.29 for Q1 2026.
- On a quarterly basis, EPS (Basic) fell 92.51% year-over-year to -$0.29 in Q1 2026; TTM through Mar 2026 was -$0.83, a 31.37% increase from a year earlier, with the FY2025 full-year figure at -$2.23, down 30.35% from the prior year.
- EPS (Basic) retreated to -$0.29 in Q1 2026 per ACRS's latest filing, from -$0.26 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$0.03 in Q4 2023 and bottomed at -$3.27 in Q4 2022.
- The 5-year median for EPS (Basic) is -$0.29 (2026), against an average of -$0.55.
- Across the five-year window, EPS (Basic) surged 99.18% in 2023 and plunged 5124.35% in 2024, its largest moves.
- Year by year, EPS (Basic) stood at -$3.27 in 2022, then jumped by 99.18% to -$0.03 in 2023, then plunged by 5124.35% to -$1.4 in 2024, then jumped by 81.76% to -$0.26 in 2025, then dropped by 13.82% to -$0.29 in 2026.
- Per Business Quant, the three latest ACRS EPS (Basic) figures stand at -$0.29 (Q1 2026), -$0.26 (Q4 2025), and -$0.16 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 0.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 0.00 |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 5.90 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -2.29 |
| 10 | Aclaris Therapeutics | 672.39 Mn | 672.39 Mn | 1.60 Mn | -0.29 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.29 |
| Dec 31, 2025 | -0.26 |
| Sep 30, 2025 | -0.16 |
| Jun 30, 2025 | -0.15 |
| Mar 31, 2025 | -0.15 |
| Dec 31, 2024 | -1.40 |
| Sep 30, 2024 | -0.14 |
| Jun 30, 2024 | -0.16 |
| Mar 31, 2024 | -0.25 |
| Dec 31, 2023 | -0.03 |
| Sep 30, 2023 | -0.47 |
| Jun 30, 2023 | -0.55 |
| Mar 31, 2023 | -0.51 |
| Dec 31, 2022 | -3.27 |
| Sep 30, 2022 | -0.55 |
| Jun 30, 2022 | -0.49 |
| Mar 31, 2022 | -0.62 |
| Dec 31, 2021 | -3.26 |
| Sep 30, 2021 | -0.63 |
| Jun 30, 2021 | -0.66 |